Identification of potential drug-related problems in the elderly: The role of the community pharmacist

Pharmacy World and Science

Volumn 28, Issue 1, 2006, Pages 33-38

  Vinks, Thijs H A M ^a,b,c   De Koning, Fred H P ^a,b,c   De Lange, Ton M ^d   Egberts, Toine C G ^a,b  

^a Brabant Institute for Pharmaceutical Research and Development (BIRD)   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c Venloon Pharmacy ^*  (Netherlands)

^d Ton de Lange Management bv   (Netherlands)

Author keywords

Community pharmacists; Drug related problems; Elderly; Medication assessment; Multiple drug use; Polypharmacy; The Netherlands

Indexed keywords

ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLURAZEPAM; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROQUININE; INSULIN; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; OXAZEPAM; PROTON PUMP INHIBITOR; TEMAZEPAM; VERAPAMIL;

AGED; ARTICLE; COMMUNITY CARE; CONSTIPATION; DRUG RELATED POTENTIAL; DRUG RELATED PROBLEM; DRUG USE; ELDERLY CARE; GASTROINTESTINAL SYMPTOM; HEART FAILURE; HIGH RISK BEHAVIOR; HOSPITAL PHARMACY; HUMAN; NETHERLANDS; PATIENT COMPLIANCE; PATIENT RELATED POTENTIAL; PHYSICAL DISEASE; POLYPHARMACY; PRESCRIBER RELATED POTENTIAL; PRESCRIPTION;

AGED; AGED, 80 AND OVER; COMMUNITY PHARMACY SERVICES; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; PHARMACEUTICAL PREPARATIONS; PHARMACISTS; POLYPHARMACY; PROFESSIONAL ROLE;

EID: 33746924087     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-005-4213-4     Document Type: Article

References (34)

1. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002; 287:337-344
2. Veehof LJ, Stewart R, Haaijer-Ruskamp FM, Meyboom-de Jong B. Chronic polypharmacy in one-third of the elderly in family practice. Ned Tijdschr Geneeskd 1999; 143:93-97
3. Masoudi FA, Krumholz HM. Polypharmacy and comorbidity in heart failure. BMJ 2003; 327:513-514
4. Murray MD, Callahan CM. Improving medication use for older adults: an integrated research agenda. Ann Intern Med 2003; 139:425-429
5. Veehof L, Stewart R, Haaijer-Ruskamp F, Jong BM. The development of polypharmacy. A longitudinal study. Fam Pract 2000; 17:261-267
6. Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004; 57:6-14
7. Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ 1997; 315:1096-1099
8. Lau HS (1998) Drug related problems in the elderly: studies on occurrence and interventions. Thesis, University of Utrecht
9. Heerdink ER (1995) Clustering of drug use in the elderly: population based studies into prevalence and outcomes. Thesis, University of Utrecht
10. van Dijk KN (2002) Pharmacotherapy in frail elderly: pharmacy data as a tool for improvement. Thesis, University of Groningen
11. Bernsten C, Bjorkman I, Caramona M, Crealey G, Frokjaer B, Grundberger E et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging 2001; 18:63-77
12. Veehof LJG (1999) Polypharmacy in the elderly. Thesis, University of Groningen
13. Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. DICP 1990; 24:1093-1097
14. Schaefer M. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci 2002; 24:120-127
15. van Mil JW, Westerlund LO, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother 2004; 38:859-867
16. KNMP (2002) Informatorium Medicamentorum. ISBN 90-70605-70-8
17. Health Base Foundation (2002) Comments on medication surveillance Pharmacom and Medicom. GrafiData, Deventer. ISBN 90-74027-17-2
18. Simon SR, Gurwitz JH. Drug therapy in the elderly: improving quality and access. Clin Pharmacol Ther 2003; 73:387-393
19. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991; 151:1825-1832
20. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997; 157:1531-1536
21. Zhan C, Sangl J, Bierman AS, Miller MR, Friedman B, Wickizer SW et al. Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA 2001; 286:2823-2829
22. Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45:1045-1051
23. Kassam R, Martin LG, Farris KB. Reliability of a modified medication appropriateness index in community pharmacies. Ann Pharmacother 2003; 37:40-46
24. Knight EL, Avorn J. Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med 2001; 135:703-710
25. Sorensen L, Grobler MP, Roberts MS. Development of a quality use of medicines coding system to rate clinical pharmacists' medication review recommendations. Pharm World Sci 2003; 25:212-217
26. Meyboom RH, Lindquist M, Egberts AC. An ABC of drug-related problems. Drug Saf 2000; 22:415-423
27. van Dijk KN, de Vries CS, van den Berg PB, Brouwers JRBJ, de Jong-van den Berg LTW. Occurrence of potential drug-drug interaction in nursing home residents. Int J Pharm Pract 2001; 9:45-52
28. Heerdink ER, Leufkens HG, Herings RM, Ottervanger JP, Stricker BH, Bakker A. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med 1998; 158:1108-1112
29. Hanlon JT, Schmader KE, Boult C, Artz MB, Gross CR, Fillenbaum GG et al. Use of inappropriate prescription drugs by older people. J Am Geriatr Soc 2002; 50:26-34
30. Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996; 100:428-437
31. Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001; 323:1340-1343
32. Pullar T, Birtwell AJ, Wiles PG, Hay A, Feely MP. Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily. Clin Pharmacol Ther 1988; 44:540-545
33. Salzman C (1995) Medication compliance in the elderly. J Clin Psychiatry 56(Suppl 1):18-22; discussion 23
34. Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging 2003; 20:817-832